Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gelofusine balanced + Sterofundin ISO is a fluid resuscitation and maintenance regimen developed by B. Braun. Gelofusine balanced is a 4% succinylated gelatin (modified fluid gelatin) solution in a balanced electrolyte carrier, used as a colloidal plasma volume substitute to treat or prevent absolute and relative hypovolemia. Sterofundin ISO (also known as Ringerfundin) is an isotonic, balanced crystalloid solution containing sodium, potassium, magnesium, calcium, chloride, acetate, and malate. The combination is designed to provide effective volume expansion through the colloid component while maintaining physiological electrolyte levels and acid-base balance through the balanced crystalloid component, specifically avoiding the hyperchloremic acidosis associated with non-balanced solutions like 0.9% saline.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on succinylated gelatin + electrolytes.